Equity
€322,053 ▲ 103%
Equity rose in 2025 from €158,945 to €322,053.
Psyscape
Overview
Lifetime
2 annual accounts with figures on one time axispeak €214,316 (2025)
€214,316▲ 2.6%
peak €163,941 (2025)
€163,941▲ 2.6%
peak €322,053 (2025)
€322,053▲ 103%
€60,449▲ 11.9%
Board1 name since 2023
1 directorSmessaert, Sarah
Documentsfilings and deeds
31-07-2026on the last day
2025micro format
Dividend €833Equity from €158,945 to €322,053Investments €4,973Cash from €132,574 to €238,089
Key points
from the 2025 annual accountsInvestments
€4,973 2.8 × depreciation
Green is investment, beige is depreciation.
Liquidity
6.16 was 3.82 in 2024
Short-term debts rose from €54,021 to €60,449.
Checked score
94
Excellent
Financially stronger than 88% of micro companies without a NACE code
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 2.5%
01-2025: 3.1%▲ +0.6 percentage points vs 12-2024
02-2025: 3.1%● unchanged vs 01-2025
03-2025: 3.4%▲ +0.3 percentage points vs 02-2025
04-2025: 3.6%▲ +0.2 percentage points vs 03-2025highest value
05-2025: 3.6%● unchanged vs 04-2025highest value
06-2025: 3.5%▼ -0.1 percentage points vs 05-2025
07-2025: 3.5%● unchanged vs 06-2025
08-2025: 0.1%▼ -3.4 percentage points vs 07-2025
09-2025: 0.1%● unchanged vs 08-2025lowest value
10-2025: 0.1%● unchanged vs 09-2025
11-2025: 0.1%● unchanged vs 10-2025
12-2025: 0.1%● unchanged vs 11-2025
01-2026: 0.1%● unchanged vs 12-2025
02-2026: 0.4%▲ +0.3 percentage points vs 01-2026
03-2026: 0.4%● unchanged vs 02-2026
04-2026: 0.5%▲ +0.1 percentage points vs 03-2026
05-2026: 0.6%▲ +0.1 percentage points vs 04-2026
06-2026: 0.7%▲ +0.1 percentage points vs 05-2026
07-2026: 0.8%▲ +0.1 percentage points vs 06-2026
08-2026: 0.2%▼ -0.6 percentage points vs 07-2026
09-2026: 0.2%● unchanged vs 08-2026
10-2026: 0.2%● unchanged vs 09-2026
11-2026: 0.2%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
raises risk
1 change of registered office in 24 months
lowers risk
Size: total assets €382,502
Liquidity: current ratio 6.16, cash €238,089
Figures for financial year 2025 (filed on 01-08-2026)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 81% of them on solvency, 87% on liquidity, 90% on profitability and 93% on growth.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 39,278 companies had the same profile as Psyscape has now. Each dot stands for 99 companies, two years later.
95.8%
were still trading
2.3%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of Psyscape itself is lower: 0.2% within 12 months. It rests on far more data about Psyscape than the profile alone.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,278 companies, not a prediction for Psyscape. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €30,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 6.16 (3.82 in 2024), above the usual 1.5. Short-term debt is 15.8% and cash 62.2% of total assets. 15.8% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-07-2026, 0 days ahead of the deadline.
NBB · 2 filingsDeviation from the deadline
2025
on the day
2024
3 days early
← before the deadline
after the deadline →
tick = median of all Belgian filings
The company filed its last 2 accounts on average 2 days before the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsWhere today falls in the filing period
10-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered office moved within Harelbeke
New registered office: Kollegelaan 23, 8530 Harelbeke · Previous registered office: Forestier Ingelramstraat 20 bus 1, 8530 Harelbeke · Board meeting of 03-11-2025 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0805916481
Incorporation
Founding capital of €1, 100 shares · Founder: Smessaert, Sarah · Appointment: Smessaert, Sarah (director) · published on 20-09-2023 · Gazette deed
First establishment
Koning Albert I-laan 8, Bruges
Official details
Source: KBO- Status
- Active since 15-09-2023Normal situation
- Activity
- “In binnen- en buitenland,voor eigen rekening of voor rekening van derden het uitoefenen van…” (deed in Dutch)From the articles, 8 activitiesNo NACE code in the KBO yet
- Establishment unit
- 2.349.732.0578200 Bruges, since 15-09-2023
- Financial year end
- 31 December
- Peppol
- Reachable since 24-11-2023
Annual accounts 2025
- €214,316▲ 2.6%
- ≈ €540,000estimated
- €163,941▲ 2.6%
- €322,053▲ 103%
- €382,502▲ 79.6%
- Filing
- Filed on 31-07-2026, on the last day of the filing period
Insights on Psyscape
Psyscape has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €322,053 and a net result of €163,941.
The computed 12-month bankruptcy probability is 0.2% (very low).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
Financials
Annual accounts 2025
micro format, filed on 31-07-2026, on the day of the deadline€214,316
▲ 2.6%
€212,274
▲ 2.1%
€163,941
▲ 2.6%
€312,001
▲ 105%
84.2%
▲ 9.6 percentage points
6.16
▲ 2.35
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €540,000. Estimated: probably between €360,000 and €830,000.
Balance sheet
balance sheet total €382,502 on 31-12-2025What the company ownsHow it is paid for
in euro
in euro
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 |
|---|---|---|---|
| Balance sheet: assets | |||
20/58 |
382,502 | 212,966 | |
21/28 |
10,051 | 6,866 | |
22/27 |
10,051 | 6,866 | |
23 |
4,930 | - | |
24 |
5,122 | 6,866 | |
29/58 |
372,450 | 206,100 | |
40/41 |
60,026 | - | |
41 |
60,026 | - | |
54/58 |
238,089 | 132,574 | |
490/1 |
74,335 | 73,526 | |
| Balance sheet: equity and liabilities | |||
10/49 |
382,502 | 212,966 | |
10/15 |
322,053 | 158,945 | |
10/11 |
1 | 1 | |
13 |
322,052 | 158,944 | |
133 |
322,052 | 158,944 | |
14 |
0 | 0 | |
17/49 |
60,449 | 54,021 | |
42/48 |
60,449 | 54,021 | |
44 |
4,019 | 28 | |
440/4 |
4,019 | 28 | |
45 |
55,127 | 52,665 | |
450/3 |
52,727 | 50,265 | |
454/9 |
2,400 | 2,400 | |
47/48 |
1,302 | 1,328 | |
| Income statement | |||
9900 |
214,316 | 208,832 | |
630 |
1,788 | 876 | |
640/8 |
254 | 50 | |
9901 |
212,274 | 207,906 | |
75/76B |
2,155 | - | |
75 |
2,155 | - | |
65/66B |
97 | 284 | |
65 |
97 | 284 | |
9903 |
214,332 | 207,623 | |
67/77 |
50,391 | 47,820 | |
9904 |
163,941 | 159,803 | |
9905 |
163,941 | 159,803 | |
| Appropriation of the result | |||
9906 |
163,941 | 159,803 | |
691/2 |
163,108 | 158,944 | |
6921 |
163,108 | 158,944 | |
694/7 |
833 | 859 | |
694 |
833 | 859 | |
| Document | |||
The notes to these accounts have 5 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 31-07-2026.
Filings
each dot is a set of accounts, on the day it reached the National BankKey figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 |
|---|---|---|---|
| 214,062 | 208,782 | ||
| 165,729 | 160,679 | ||
| 4,973 | 7,742 | ||
| 105,515 | - | ||
| 312,001 | 152,079 | ||
| 84.2% | 74.6% | ||
| 6.16 | 3.82 | ||
| 0.19 | 0.34 | ||
| 50.9% | 100.5% | ||
| 42.9% | 75.0% | ||
| over 100 | over 100 |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Investments
fixed assets acquired| Item | 2025 | 2024 |
|---|---|---|
| Tangible fixed assets | €4,973 | €7,742 |
| €1,788 | €876 |
Source: notes to the 2024 to 2025 annual accounts (statement of fixed assets)
Insights on Psyscape
The operating result for 2025 is 2% higher than in 2024.
Debt's share of the balance-sheet total falls from 25.4% to 15.8%. Equity and debt are higher.
Board & ownership
Board
1 director, since incorporationDirector (not named in the articles)
since 13-09-2023
term without a fixed end
listed in the 2025 annual accounts, filed on 31-07-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Artikel 13. Externe vertegenwoordiging van de vennootschap Iedere bestuurder-arts-aandeelhouder afzonderlijk, ook zo er meerdere zijn, heeft…”deed of 20-09-2023
Mandates through the years
1 name, the dashed line is todaySmessaert, Sarah
Director (not named in the articles)
Director (not named in the articles)
Board
Mandates as a list
- Smessaert, Sarah
- Director (not named in the articles), from 13-09-2023 to date
Control
Capital
- Contribution
- €1
- Shares
- 100
- Contribution per share
- €0.01
- Equity per share
- €3,221 in 2025
- Source
- deed of 20-09-2023
Articles of association
deed of 20-09-2023 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Helft overdrager,helft kopers naar evenredigheid aantal, werkelijke waarde op dag overdracht,bij onenigheid deskundigen als bij overlijden”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Friday of June at 14:00
Shareholders
At incorporation
deed of 20-09-2023 ↗
- Smessaert, Sarah 100 shares (100%) · in cash
Network & group
No group
Psyscape has no parent and no holdings in its annual accounts. Smessaert, Sarah is the only director. Psyscape shares no director with another company.
Timeline
Timeline
7 events since 2023Filings
Financial
Establishments
Address
2023202420252026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBmicro format · on the deadline day
Registered office moved within HarelbekeNew registered office: Kollegelaan 23, 8530 Harelbeke · Previous registered office: Forestier Ingelramstraat 20 bus 1, 8530 Harelbeke · Board meeting of 03-11-20252 points ▸
- Board meeting, 03-11-2025
- Registered-office move, Kollegelaan 23, 8530 Harelbeke
2025
Equity above €200,000 equity €322,053 ▲103% With a profit in every financial year since 2024, equity grows to €322,053.
Annual accounts 2024 filed PDFmicro format · 3 days before the deadline
2023
Registered in the Peppol Directory Reachable for e-invoices through 0208:0805916481
IncorporationFounding capital of €1, 100 shares · Founder: Smessaert, Sarah · Appointment: Smessaert, Sarah (director) · published on 20-09-20234 points ▸
- Founder, Smessaert, Sarah
- Registered office clause, Forestier Ingelramstraat 20 bus 0001, 8530 Harelbeke
- Founding capital, €1, 100 shares
- Director appointment, Smessaert, Sarah (director (not named in the articles))
First establishment Koning Albert I-laan 8, Bruges
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
On 15 September 2023, Psyscape was incorporated as a private limited company by one natural person, with a starting capital of €1.12 In 2026 the registered office moved to Harelbeke.3 Smessaert, Sarah has served as director since 2023.4
Company details
Identity
- Enterprise number
- 0805.916.481
- VAT number
- BE 0805.916.481
- Peppol ID
- 0208:0805916481
- Other Peppol ID
- 9925:BE0805916481
- Legal form
- Private limited company
- Status
- Active, normal situation
- Founded
- 15-09-2023
- Financial year
- ends on 31 December
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Friday of June at 14:00deed of 20-09-2023 (in Dutch)
- Peppol
- Reachable since 24-11-2023Follow this company and you will hear the next morning if it leaves the Peppol register.
- Name
- Psyscape in Dutch
- Entity type
- Legal entity
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 20-09-2023 (in Dutch)
- Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
- “Vlaams Gewest”deed of 20-09-2023 (in Dutch)
Activities
- PurposeThe purpose describes the activities the company may carry out under its articles.
- “In binnen- en buitenland,voor eigen rekening of voor rekening van derden het uitoefenen van de geneeskunde door een arts-aandeelhouder…”deed of 20-09-2023 (in Dutch)
8 activities
- In binnen- en buitenland,voor eigen rekening of voor rekening van derden het uitoefenen van de geneeskunde door een arts-aandeelhouder algemeen,onder meer-doch niet beperkend-op het gebied van de psychiatrie en psychotherapie rekening houdend met de regels van de Medische Deontologie,op voorwaarde dat hij ingeschreven is op de lijst van de Orde der Artsen,met dien verstande dat het geheel of een deel van de medische activiteiten worden uitgeoefend in naam en voor rekening van de vennootschap en alle daaruit voortvloeiende honoraria geïnd worden door en voor de vennootschap.
- Het inrichten van algemene diensten en een medisch secretariaat in het bijzonder die nuttig of nodig zijn voor de uitoefening van voormelde activiteit;
- De aankoop,het huren en/of leasen van alle medische apparatuur en begeleidende accommodaties,inclusief gebouwen,kortom van een volledige materiële infrastructuur om deze ter beschikking te stellen van de arts-aandeelhouder;
- Het scheppen van de mogelijkheden om de arts-aandeelhouder toe te laten zich verder te bekwamen in voormelde medische discipline,dit teneinde een kwalitatief hoogstaande praktijkuitoefening mogelijk te maken;
- Het verstrekken van informatie en/of onderricht inzake de geneeskunde in het algemeen en de psychiatrie en psychotherapie in het bijzonder en dit in de breedste betekenis van het woord,zonder dat dit de vorm van een aanvullende commerciële activiteit mag aannemen;
- Activiteiten in eerbied met deontologische en administratieve voorschriften,medische deontologie,medische ethiek,eisen wetenschappelijke discipline
- Vrije artsenkeuze,diagnostische en therapeutische vrijheid,medisch beroepsgeheim blijven behouden
- Professionele onafhankelijkheid arts-aandeelhouder gewaarborgd,geen commerciële beoefening,directe of indirecte collusie,dichotomie of overconsumptie
Registered office and establishments
1 establishment| Establishment | Since | Unit number |
|---|---|---|
| Kollegelaan 23 registered office 8530 Harelbeke | ||
| Koning Albert I-laan 8 8200 Bruges 85592 Vocational training | 15-09-2023 | 2.349.732.057 |
Buildings and parcels at the addresses
- Ground area
- 16.4 ha
- Buildings
- 2.2 ha
- Volume, LiDAR
- 146,230 m³
- Tallest building
- 33.0 m
Buildings to scale, each on its own parcel
Parcels
| Cadastral parcel | Area | Buildings | Height / floors |
|---|---|---|---|
| 31030A0014/00S000 | 16.4 ha | 1 · 2.2 ha | 33.0 m · 2 |
| 34322B0438/00M002 | 655 m² | 1 · 158 m² | 4.9 m · 1 |
1 of these parcels carries protected heritage. Expect extra rules on renovation or sale.